Clinical Pharmacology and Drug Toxicity — MCQs
On this page
Headache and papilledema are features of toxicity of which vitamin?
Which of the following is the first-line treatment for Wilson's disease?
Which of the following drugs is associated with priapism?
Which compound is primarily responsible for the hepatotoxicity associated with Isoniazid (INH)?
What is the recommended treatment for clopidogrel toxicity?
Which of the following is teratogenic?
After how many weeks of metoclopramide use does the risk of developing tardive dyskinesia significantly increase?
In the context of patients with liver failure, how does temazepam compare to diazepam?
Why is clopidogrel preferred over ticlopidine?
Which drug is given in the pain due to diabetic neuropathy?
Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs
Question 851: Headache and papilledema are features of toxicity of which vitamin?
- A. Vitamin A (Correct Answer)
- B. Vitamin D
- C. Vitamin C
- D. Vitamin E
Explanation: ***Vitamin A*** - **Vitamin A toxicity** (hypervitaminosis A) can lead to increased **intracranial pressure**, manifesting as **headache** and **papilledema**. - Other symptoms may include **dry skin**, **cheilosis**, **hepatomegaly**, and **bone pains**. *Vitamin D* - **Vitamin D toxicity** is primarily characterized by **hypercalcemia**, which can lead to symptoms like **nausea**, **vomiting**, **polyuria**, and **renal stones**. - It does not typically cause papilledema or increased intracranial pressure directly. *Vitamin C* - **Vitamin C toxicity** is rare due to its water-soluble nature, but very high doses can cause **gastrointestinal upset** (diarrhea) and **kidney stones**. - It is not associated with neurological symptoms like headache or papilledema. *Vitamin E* - **Vitamin E toxicity** is uncommon, but high doses can interfere with **blood clotting** and increase the risk of **bleeding**, especially in patients taking anticoagulants. - It is not associated with increased intracranial pressure or papilledema.
Question 852: Which of the following is the first-line treatment for Wilson's disease?
- A. Deferasirox
- B. Penicillamine (Correct Answer)
- C. Zinc acetate
- D. Trientine
Explanation: ***Penicillamine*** - **Penicillamine** is the **traditional first-line treatment** for Wilson's disease according to international guidelines (AASLD, EASL) and standard medical practice. - It is a **copper chelator** that binds to copper and promotes its urinary excretion, effectively reducing copper accumulation in tissues. - It is used for both **initial treatment** of symptomatic patients (hepatic or neurological) and for **presymptomatic patients**. - Common side effects include early hypersensitivity reactions, bone marrow suppression, proteinuria, and late autoimmune phenomena, but it remains the most widely used first-line agent. *Trientine* - **Trientine** is a **second-line copper chelator** used when patients are **intolerant to penicillamine** or develop adverse effects. - It has a **better safety profile** than penicillamine with fewer side effects, but is reserved as an alternative rather than initial therapy. - It works similarly by chelating copper and promoting urinary excretion. *Zinc acetate* - **Zinc acetate** is primarily used for **maintenance therapy** in stable patients or for **presymptomatic patients** detected through family screening. - It works by **blocking intestinal copper absorption** by inducing metallothionein in enterocytes. - It is **not effective for initial treatment** of symptomatic patients as it does not remove existing copper stores and takes months to be effective. *Deferasirox* - **Deferasirox** is an **iron chelator** used to treat iron overload in conditions like thalassemia major. - It has **no role in Wilson's disease**, which involves copper overload, not iron.
Question 853: Which of the following drugs is associated with priapism?
- A. Hydralazine
- B. Risperidone
- C. Prazosin
- D. Both risperidone and prazosin (Correct Answer)
Explanation: ***Both risperidone and prazosin*** - This is the **correct answer** because both drugs are well-established causes of drug-induced priapism - **Risperidone** (atypical antipsychotic): Causes priapism through **alpha-1 adrenergic receptor blockade**, reducing venous outflow from corpora cavernosa (reported incidence: 0.3-1%) - **Prazosin** (alpha-1 blocker): Directly causes priapism by inhibiting **alpha-1 mediated vasoconstriction** in penile vasculature, preventing detumescence - Both share the **same mechanism**: alpha-1 receptor antagonism leading to prolonged penile engorgement *Hydralazine* - A direct-acting **arterial vasodilator** used for hypertension - Works by relaxing arterial smooth muscle through unclear mechanisms (possibly involving nitric oxide) - **Not associated with priapism** - lacks alpha-adrenergic blocking effects - Different mechanism makes it an incorrect choice *Risperidone (alone)* - While medically accurate that risperidone causes priapism, this option is **incomplete** - The question tests comprehensive knowledge of ALL drugs causing this serious adverse effect - Selecting only risperidone misses prazosin, another well-documented cause *Prazosin (alone)* - While medically accurate that prazosin causes priapism, this option is **incomplete** - The question tests comprehensive knowledge of ALL drugs causing this serious adverse effect - Selecting only prazosin misses risperidone, another well-documented cause **Clinical Pearl:** Drug-induced priapism is a urological emergency requiring prompt treatment to prevent permanent erectile dysfunction. Other drugs associated with priapism include trazodone, phenothiazines, and other alpha-blockers.
Question 854: Which compound is primarily responsible for the hepatotoxicity associated with Isoniazid (INH)?
- A. INH sulfhydrazine
- B. INH methylhydrazine
- C. INH acetylhydrazine (Correct Answer)
- D. None of the options
Explanation: ***INH acetylhydrazine*** - The hepatotoxicity of Isoniazid (INH) is primarily attributed to **acetylhydrazine**, a toxic metabolite formed during INH metabolism - **Metabolic pathway:** INH is first acetylated by N-acetyltransferase 2 (NAT2) to form acetylisoniazid, which then hydrolyzes to **acetylhydrazine** and isonicotinic acid - Acetylhydrazine is further oxidized by **cytochrome P450 2E1 (CYP2E1)** to form highly reactive intermediates that covalently bind to hepatic macromolecules, causing **hepatocellular injury** - **Risk factors:** Rapid acetylators, concurrent alcohol use, and CYP2E1 inducers increase acetylhydrazine formation and hepatotoxicity risk - This is the well-established mechanism of INH-induced hepatitis in clinical pharmacology *INH sulfhydrazine* - Sulfhydrazine is not a metabolite of isoniazid - INH metabolism involves acetylation and hydrolysis, not sulfonation pathways - This compound is not implicated in INH hepatotoxicity *INH methylhydrazine* - Methylhydrazine is not formed during isoniazid metabolism - The metabolic pathway of INH involves acetylation, not methylation - While hydrazine compounds can be hepatotoxic, methylhydrazine is not relevant to INH toxicity *None of the options* - This is incorrect as acetylhydrazine (listed as "INH acetylhydrazine") is indeed the primary toxic metabolite responsible for hepatotoxicity
Question 855: What is the recommended treatment for clopidogrel toxicity?
- A. Whole human blood
- B. vWf transfusion
- C. rFVIIa infusion
- D. Platelet transfusion (Correct Answer)
Explanation: ***Platelet transfusion*** - **Clopidogrel** is an **antiplatelet** agent that irreversibly inhibits the P2Y12 receptor on platelets, preventing aggregation. - In cases of toxicity or significant bleeding, **platelet transfusion** provides new, uninhibited platelets to restore hemostasis. *Whole human blood* - While whole blood contains platelets, it is generally **not the primary treatment** for clopidogrel toxicity. - **Whole blood transfusions** are reserved for massive hemorrhage with significant blood volume loss, providing red blood cells, plasma, and platelets. *vWf transfusion* - **Von Willebrand factor (vWF)** is crucial for platelet adhesion and aggregation, particularly in primary hemostasis. - **vWF transfusion** is indicated in von Willebrand disease, not clopidogrel toxicity, as clopidogrel specifically targets platelet activation, not vWF levels. *rFVIIa infusion* - **Recombinant activated factor VII (rFVIIa)** is a procoagulant agent that promotes thrombin generation. - It is used in certain bleeding disorders or severe refractory bleeding, but it does **not directly reverse the antiplatelet effect of clopidogrel**.
Question 856: Which of the following is teratogenic?
- A. Folate
- B. Cyanocobalamin
- C. Vitamin A (Correct Answer)
- D. Vitamin C
Explanation: ***Vitamin A*** - High doses of **preformed vitamin A (retinoids)**, both natural and synthetic, can be teratogenic, leading to birth defects. - Excessive vitamin A intake during pregnancy is associated with abnormalities affecting the **craniofacial, central nervous, and cardiovascular systems**. *Folate* - Folate is an **essential nutrient for fetal development** and is crucial for preventing neural tube defects. - It is **not teratogenic**; in fact, supplementation is routinely recommended to pregnant women. *Cyanocobalamin* - **Cyanocobalamin (Vitamin B12)** is not considered teratogenic and plays a vital role in fetal growth and neurological development. - Deficiencies, rather than excesses, are a concern during pregnancy, potentially leading to developmental issues. *Vitamin C* - **Vitamin C** is an antioxidant and is not known to be teratogenic; it is an important nutrient during pregnancy. - While extremely high doses could theoretically have mild side effects, it does not cause birth defects and is generally considered safe.
Question 857: After how many weeks of metoclopramide use does the risk of developing tardive dyskinesia significantly increase?
- A. 8
- B. 12 (Correct Answer)
- C. 16
- D. 20
Explanation: ***12 weeks***- The FDA issued a **BLACK BOX WARNING** limiting metoclopramide use to **≤12 weeks** due to significantly increased risk of **tardive dyskinesia** beyond this threshold- This is the critical duration where re-evaluation of therapy necessity is mandated to minimize irreversible neurological complications- **Clinical guideline**: Maximum duration of 12 weeks for most indications*8 weeks*- While adverse effects can occur with any duration of use, the **significant risk threshold** for tardive dyskinesia is at 12 weeks, not 8- This duration is still within the safer treatment window*16 weeks*- This exceeds the **FDA-recommended maximum duration**- By 16 weeks, the risk is already substantially elevated, making this well beyond the threshold where risk "significantly increases"*20 weeks*- This represents prolonged exposure far exceeding safety guidelines- The significant risk increase occurs much earlier (at 12 weeks), making this an extended period of inappropriate use
Question 858: In the context of patients with liver failure, how does temazepam compare to diazepam?
- A. Has a longer duration of action than diazepam
- B. Safer for patients with liver failure (Correct Answer)
- C. Undergoes extensive hepatic metabolism
- D. Has active metabolites that can accumulate in liver failure
Explanation: ***Safer for patients with liver failure*** - Temazepam is primarily metabolized by **conjugation** (glucuronidation), resulting in inactive metabolites that are readily excreted by the kidneys. - This metabolic pathway is generally less impaired in the presence of **liver dysfunction** compared to oxidative metabolism. *Has a longer duration of action than diazepam* - Temazepam generally has a **shorter half-life** and duration of action compared to diazepam. - Diazepam's prolonged effect is largely due to its **active metabolites** which have long half-lives. *Undergoes extensive hepatic metabolism* - While temazepam does undergo hepatic metabolism, its primary pathway is **conjugation**, which is less reliant on the oxidative enzyme systems that are often compromised in liver failure. - In contrast, diazepam undergoes extensive **oxidative metabolism**, making it more problematic in liver dysfunction. *Has active metabolites that can accumulate in liver failure* - Temazepam's main metabolites are **inactive glucuronides**, which do not accumulate to produce significant pharmacological effects, even in liver failure. - **Diazepam**, however, is metabolized to active compounds like **desmethyldiazepam** and **oxazepam**, which can accumulate and cause prolonged sedation in liver failure.
Question 859: Why is clopidogrel preferred over ticlopidine?
- A. Lower incidence of neutropenia and thrombocytopenia (Correct Answer)
- B. Lower incidence of dyslipidemia
- C. Lower incidence of hyperglycemia
- D. Lower incidence of postural hypotension
Explanation: **Lower incidence of neutropenia and thrombocytopenia** - **Clopidogrel** has a significantly **lower risk** of causing severe hematologic side effects like **neutropenia** and **thrombocytopenia** compared to ticlopidine. - This improved safety profile makes clopidogrel the **preferred antiplatelet agent** in clinical practice due to reduced monitoring requirements and increased patient safety. *Lower incidence of dyslipidemia* - Neither clopidogrel nor ticlopidine are primarily associated with a significant incidence of **dyslipidemia** as a direct side effect. - **Dyslipidemia** is more commonly managed through lifestyle changes and lipid-lowering medications like statins. *Lower incidence of hyperglycemia* - Both clopidogrel and ticlopidine are not known to directly cause or exacerbate **hyperglycemia**. - **Hyperglycemia** is typically associated with diabetes mellitus or certain medications like corticosteroids. *Lower incidence of postural hypotension* - **Postural hypotension** is not a common or significant side effect associated with either clopidogrel or ticlopidine. - **Postural hypotension** is more frequently linked to medications affecting the autonomic nervous system or volume status.
Question 860: Which drug is given in the pain due to diabetic neuropathy?
- A. Lamotrigine
- B. Na valproate
- C. Gabapentin (Correct Answer)
- D. Morphine
Explanation: ***Gabapentin*** - **Gabapentin** is a first-line agent often prescribed for neuropathic pain, including that caused by **diabetic neuropathy**. - It works by modulating voltage-gated **calcium channels**, reducing neurotransmitter release in the pain pathways. *Lamotrigine* - While an antiepileptic drug, **lamotrigine** is primarily used for **epilepsy** and **bipolar disorder**. - It is not a first-line treatment for **diabetic neuropathic pain**. *Na valproate* - **Sodium valproate** is an anticonvulsant and mood stabilizer, mainly used for epilepsy, **bipolar disorder**, and **migraine prophylaxis**. - It is not typically recommended for the management of **diabetic neuropathic pain**. *Morphine* - **Morphine** is a strong opioid analgesic used for severe acute or chronic pain. - While it can alleviate pain, it is generally considered a **second-line or third-line agent** for **neuropathic pain** due to risks of dependence and side effects.
Practice by Chapter
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free